JW HOLDINGS CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,980 KRW | -1.00% |
|
+0.68% | -14.61% |
| Mar. 20 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
| Mar. 18 | JW Holdings Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
JW Holdings Corp is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through four segments. The Pharmaceutical segment is involved in the manufacturing and sale of pharmaceuticals. Its major products include antibiotics, antifungal agents, blood and body fluids substitutes, hyperlipidemia drugs, electrolyte additives, angina pills, and digestive medicines. The Medical Equipment segment manufactures and sells medical equipment such as diagnostic equipment, diagnostic reagents, surgical operating tables, and surgical mooyoung lamp. The Holding Business segment manages affiliated companies within the group. The Other segment is involved in the manufacturing and sale of automotive supplies, as well as the real estate investment.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.61% | 156M | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- A096760 Stock
- News JW Holdings Corporation
- JW (Cayman) Therapeutics Signs Collaboration Deal for Development of Autoimmune Disease Treatment
